Silence Therapeutics PLC (SLN)
13.98
-1.30
(-8.54%)
USD |
NASDAQ |
Nov 14, 16:00
13.98
0.00 (0.00%)
After-Hours: 20:00
Silence Therapeutics Gross Profit Margin (Quarterly): -341.1% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -341.1% |
| March 31, 2024 | 82.16% |
| December 31, 2023 | 35.87% |
| September 30, 2023 | 42.57% |
| June 30, 2023 | 68.90% |
| March 31, 2023 | 60.14% |
| December 31, 2022 | 19.01% |
| September 30, 2022 | 28.98% |
| Date | Value |
|---|---|
| June 30, 2022 | 35.44% |
| March 31, 2022 | 60.24% |
| December 31, 2021 | 40.19% |
| September 30, 2021 | 34.98% |
| June 30, 2021 | 32.43% |
| March 31, 2021 | 51.11% |
| December 31, 2020 | 38.98% |
| September 30, 2020 | -17.25% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-341.1%
Minimum
Jun 2024
82.16%
Maximum
Mar 2024
17.04%
Average
37.43%
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.89% |
| Return on Assets | -29.98% |
| Return on Invested Capital | -69.89% |
| Profit Margin (Quarterly) | -2.60K% |
| Operating Margin (Quarterly) | -3.06K% |
| Return on Net Operating Assets | -112.5% |